Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Dextromethorphan and Adrenocorticotropic Hormone

Research Papers that Mention the Interaction

A reduced DEX suppression of baseline secretion of ACTH appeared 3 weeks after defeat.
DEX pretreatment inhibited pituitary adrenocortical activity, reflected both in reduced baseline and response values of ACTH and CORT.
The ACTH response to CRF following DEX administration was significantly higher in defeated rats as compared to controls both at one and three weeks after defeat.
Journal of neuroendocrinology  •  1999  |  View Paper
With increasing DEX doses, ACTH and cortisol values decreased in young adult participants, while the decrease was blunted among elderly compared to young adult participants.
Journal of psychiatric research  •  2011  |  View Paper
After the administration of math and speech stressors in a controlled laboratory setting, DEX inhibited the ACTH and cortisol release that was noted in the saline group, but stress-induced increases in EPI and NEPI were comparable in both groups.
DEX produced a dramatic decrease in ACTH and cortisol levels, but no significant changes in EPI or NEPI occurred over a 4-h sampling interval.
The Journal of clinical endocrinology and metabolism  •  1995  |  View Paper
Basal ACTH and cortisol secretion remained suppressed throughout the night during both the Dex + ITT and Dex + hCRH + ITT studies when compared to the control study (cITT, P < 0.05).
The Journal of clinical endocrinology and metabolism  •  1992  |  View Paper
DEX showed significantly lowered ACTH concentrations from the day of drug injection (p<0.05).
Analytica chimica acta  •  2007  |  View Paper
Although both dextromethorphan and dextrorphan increased plasma levels of adrenocorticotropic hormone (ACTH) and corticosterone, the dextromethorphan-induced responses occurred more rapidly than the dextrorphan-induced responses.
Journal of Pharmacology and Experimental Therapeutics  •  2004  |  View Paper
This was evidenced in the latter animals by the fact that DEX was significantly less able to suppress the secretion of ACTH and corticosterone, and by a significantly higher release of ACTH after administration of CRF.
Psychoneuroendocrinology  •  1999  |  View Paper
After DEX treatment, basal ACTH levels between 18.00 and 20.00 h were significantly higher in aged than in young rats (77.6 +/- 23.2 vs. 19.9 +/- 0.9 pg/ml; p < 0.01), indicating resistance of the HPA system to the suppressive effect of DEX.
DEX (30 micrograms/kg) administered at 12.00 h, during the diurnal trough, suppressed the diurnal increase in circulating corticotropin (ACTH) and corticosterone between 18.00 and 20.00 h, during the acrophase.
Neuroendocrinology  •  1996  |  View Paper
We report an ICV DEX injection protocol (10 microgram given four times) that results in blocking the stress-induced release of ACTH and corticosterone, and attenuating the stress-induced release of plasma E and NE.
Psychoneuroendocrinology  •  1993  |  View Paper
DEX attenuated the vasopressin and ACTH responses to each infusion.
The American journal of physiology  •  1986  |  View Paper
Show More